Nasdaq · Healthcare
UFP TECHNOLOGIES INC (UFPT)
As-reported financials and recent SEC filings for UFP TECHNOLOGIES INC, latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$602.8M
Net income
$68.3M
Net margin
11.3%
Diluted EPS
$8.75
ROE
16.1%
P/E (TTM)
29.6×
Market cap
$2.01B
Debt / equity
0.3×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $602.8M | $504.4M | $400.1M | $353.8M | $206.3M |
| Gross profit | $170.4M | $146.7M | $112.2M | $90.3M | $51.1M |
| Operating income | $92.3M | $80.9M | $57.7M | $55.4M | $21.2M |
| Net income | $68.3M | $59.0M | $44.9M | $41.8M | $15.9M |
| Diluted EPS | $8.75 | $7.58 | $5.83 | $5.45 | $2.09 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-06-15
View on EDGAR →1442026-06-12
View on EDGAR →8-K2026-06-10
View on EDGAR →42026-06-08
View on EDGAR →42026-06-08
View on EDGAR →32026-06-08
View on EDGAR →42026-06-08
View on EDGAR →42026-06-08
View on EDGAR →Go deeper on UFPT
Search UFP TECHNOLOGIES INC’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.